E. Nigra

465 total citations
10 papers, 285 citations indexed

About

E. Nigra is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, E. Nigra has authored 10 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 7 papers in Genetics. Recurrent topics in E. Nigra's work include Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). E. Nigra is often cited by papers focused on Viral-associated cancers and disorders (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). E. Nigra collaborates with scholars based in Italy, United States and Austria. E. Nigra's co-authors include Umberto Tirelli, Michele Spina, Emanuela Vaccher, Ulrich Jaeger, Joseph A. Sparano, Renato Talamini, Giuseppe Rossi, Massimiliano Berretta, Armin Rieger and Mariagrazia Michieli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

E. Nigra

10 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Nigra Italy 7 247 205 77 60 41 10 285
Dennis A. Lowenthal United States 5 257 1.0× 192 0.9× 63 0.8× 79 1.3× 69 1.7× 8 339
Benjamin Tan United States 6 205 0.8× 138 0.7× 52 0.7× 32 0.5× 46 1.1× 9 261
Jan Thoden Germany 8 140 0.6× 112 0.5× 31 0.4× 44 0.7× 55 1.3× 14 236
A.A. Armstrong United Kingdom 6 278 1.1× 252 1.2× 27 0.4× 31 0.5× 54 1.3× 8 335
E Navratil France 6 94 0.4× 121 0.6× 20 0.3× 48 0.8× 72 1.8× 9 298
June Freeland United Kingdom 9 295 1.2× 296 1.4× 45 0.6× 48 0.8× 35 0.9× 9 384
Fahmida Shaik South Africa 7 232 0.9× 136 0.7× 19 0.2× 35 0.6× 67 1.6× 11 284
William Wu United States 9 173 0.7× 86 0.4× 13 0.2× 32 0.5× 92 2.2× 20 276
Joanna Romejko‐Jarosińska Poland 8 127 0.5× 220 1.1× 67 0.9× 64 1.1× 17 0.4× 42 305
Gottfried Doelken Germany 8 174 0.7× 179 0.9× 68 0.9× 77 1.3× 6 0.1× 15 296

Countries citing papers authored by E. Nigra

Since Specialization
Citations

This map shows the geographic impact of E. Nigra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Nigra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Nigra more than expected).

Fields of papers citing papers by E. Nigra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Nigra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Nigra. The network helps show where E. Nigra may publish in the future.

Co-authorship network of co-authors of E. Nigra

This figure shows the co-authorship network connecting the top 25 collaborators of E. Nigra. A scholar is included among the top collaborators of E. Nigra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Nigra. E. Nigra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Spina, Michele, Ulrich Jaeger, Joseph A. Sparano, et al.. (2004). Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood. 105(5). 1891–1897. 125 indexed citations
2.
Tirelli, Umberto, Michele Spina, Ulrich Jaeger, et al.. (2002). Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study. Recent results in cancer research. 159. 149–153. 32 indexed citations
3.
Spina, Michele, Guglielmo Nasti, Marco Fasan, et al.. (2001). Human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer. 92(1). 200–206. 20 indexed citations
4.
Nasti, Guglielmo, D. Errante, Renato Talamini, et al.. (2000). Vinorelbine Is an Effective and Safe Drug for AIDS-Related Kaposi’s Sarcoma: Results of a Phase II Study. Journal of Clinical Oncology. 18(7). 1550–1557. 40 indexed citations
5.
Spina, Michele, D. Errante, Jean Gabarre, et al.. (1999). FEASIBILITY OF THE INTEGRATION OF STANFORD V CHEMOTHERAPY (CT) REGIMEN WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) AND G-CSF IN PATIENTS (PTS) WITH HODGKIN'S DISEASE AND HIV INFECTION (HD-HIV).. JAIDS Journal of Acquired Immune Deficiency Syndromes. 21(1). A39–A39. 11 indexed citations
6.
Tirelli, Umberto, Michele Spina, Jean Gabarre, et al.. (1999). TREATMENT OF HIV-RELATED NON-HODGKIN'S LYMPHOMA ADAPTED TO PROGNOSTIC FACTORS.. JAIDS Journal of Acquired Immune Deficiency Syndromes. 21(1). A32–A32. 17 indexed citations
7.
Errante, D., Andrea Antinori, P Caramello, et al.. (1998). SECOND-LINE CHEMOTHERAPY (CT) WITH CDE (CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE) IN PATIENTS (PTS) WITH RESISTANT HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKIN'S LYMPHOMA (HIV-NHL). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A30–A30. 3 indexed citations
8.
Gisselbrecht, Christian, Michele Spina, Jean Gabarre, et al.. (1997). THERAPY OF HIV-RELATED NON-HODGKIN'S LYMPHOMA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A53–A53. 3 indexed citations
9.
10.
Nigra, E., et al.. (1988). 5-Methyltetrahydrofolic Acid (MFH4): An Effective Folate for the Treatment of Advanced Colorectal Cancer with 5-FU. Recent results in cancer research. 110. 219–225. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis A. Lowenthal Breakdown of academic impact, for papers by Benjamin Tan Breakdown of academic impact, for papers by Jan Thoden Breakdown of academic impact, for papers by A.A. Armstrong Breakdown of academic impact, for papers by E Navratil Breakdown of academic impact, for papers by June Freeland Breakdown of academic impact, for papers by Fahmida Shaik Breakdown of academic impact, for papers by William Wu Breakdown of academic impact, for papers by Joanna Romejko‐Jarosińska Breakdown of academic impact, for papers by Gottfried Doelken
Rankless by CCL
2026